{"id":46275,"date":"2025-11-17T14:39:44","date_gmt":"2025-11-17T12:39:44","guid":{"rendered":"https:\/\/www.incliva.es\/services\/researcher-services\/scientific-management\/innovation-support-unit\/oferta-tecnologica-spin-offs\/"},"modified":"2026-09-16T11:04:55","modified_gmt":"2026-09-16T09:04:55","slug":"technology-portfolio-spin-offs","status":"publish","type":"page","link":"https:\/\/www.incliva.es\/en\/services\/researcher-services\/scientific-management\/innovation-unit\/technology-portfolio-spin-offs\/","title":{"rendered":"Technology Portfolio \/ Spin-Offs"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-text fusion-text-1\" style=\"transform:translate3d(0,0,0);\"><h5>Technological Offer<\/h5>\n<p>Since its formal establishment as a Biomedical Research Institute in 2010, INCLIVA has achieved significant milestones arising from its research activities. These include more than 20 patents, 4 registered software programs, and 4 spin-off companies created as a result of research conducted at INCLIVA.<\/p>\n<\/div><style type=\"text\/css\">.fusion-accordian  #accordion-46275-1 .panel-title a .fa-fusion-box{ color: #ffffff;}.fusion-accordian  #accordion-46275-1 .panel-title a .fa-fusion-box:before{ font-size: 14px; width: 14px;}.fusion-accordian  #accordion-46275-1.fusion-toggle-icon-right .fusion-toggle-heading{ margin-right: 32px;}.fusion-accordian  #accordion-46275-1 .panel-title a{font-size:14px;}.fusion-accordian  #accordion-46275-1 .fa-fusion-box { background-color: #212934;border-color: #212934;}.fusion-accordian  #accordion-46275-1 .panel-title a:hover, #accordion-46275-1 .fusion-toggle-boxed-mode:hover .panel-title a { color: #3d44ac;}.fusion-accordian  #accordion-46275-1 .panel-title .active .fa-fusion-box,.fusion-accordian  #accordion-46275-1 .panel-title a:hover .fa-fusion-box { background-color: #3d44ac!important;border-color: #3d44ac!important;}<\/style><div class=\"accordian fusion-accordian\"><div class=\"panel-group fusion-toggle-icon-right\" id=\"accordion-46275-1\" role=\"tablist\"><div class=\"fusion-panel panel-default\" role=\"tabpanel\"><div class=\"panel-heading\"><h4 class=\"panel-title toggle\"><a class=\"active\" aria-expanded=\"true\" aria-selected=\"true\" aria-controls=\"4f5bc88639892583e\" role=\"tab\" data-toggle=\"collapse\" data-parent=\"#accordion-46275-1\" data-target=\"#4f5bc88639892583e\" href=\"#4f5bc88639892583e\"><span class=\"fusion-toggle-icon-wrapper\" aria-hidden=\"true\"><i class=\"fa-fusion-box\" aria-hidden=\"true\"><\/i><\/span><span class=\"fusion-toggle-heading\">Results<\/span><\/a><\/h4><\/div><div id=\"4f5bc88639892583e\" class=\"panel-collapse collapse in\"><div class=\"panel-body toggle-content fusion-clearfix\">\n<div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-flex-start\" style=\"width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-0 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-2\" style=\"transform:translate3d(0,0,0);\"><p><strong>OPTIMIZATION DEVICE FOR INTRAURETHRAL LUBRICATION IN PEDIATRIC PATIENTS<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-3\" style=\"transform:translate3d(0,0,0);\"><p><strong>Group:<\/strong> Urolog\u00eda<\/p>\n<\/div><div class=\"fusion-text fusion-text-4\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Modelo de utilidad<\/p>\n<\/div><div class=\"fusion-text fusion-text-5\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/03\/Oferta-tecnologica_en_i2021_10.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-0{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-0{width:50% !important;order : 0;}.fusion-builder-nested-column-0 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-0{width:100% !important;order : 0;}.fusion-builder-nested-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-1 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-6\" style=\"transform:translate3d(0,0,0);\"><p><strong>Novel treatment with PPAR modulators for metabolic diseases<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-7\" style=\"transform:translate3d(0,0,0);\"><p><strong>Group: <\/strong>Qu\u00edmica M\u00e9dica<\/p>\n<\/div><div class=\"fusion-text fusion-text-8\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-9\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/03\/Oferta-Tecnologica_EN_i2024_02.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-1{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-1 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-1{width:50% !important;order : 0;}.fusion-builder-nested-column-1 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-1{width:100% !important;order : 0;}.fusion-builder-nested-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-2 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-10\" style=\"transform:translate3d(0,0,0);\"><p><strong>Cathlab Sim: SOFTWARE FOR THE SIMULATION OF PERCUTANEOUS CARDIAC INTERVENTIONS AND THE TRAINING OF HEALTHCARE STAFF<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-11\" style=\"transform:translate3d(0,0,0);\"><p><strong>Group:<\/strong> Cardiolog\u00eda Cl\u00ednica<\/p>\n<\/div><div class=\"fusion-text fusion-text-12\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-13\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/03\/Oferta-tecnologica_en_i2020-13.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-2{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-2 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-2{width:50% !important;order : 0;}.fusion-builder-nested-column-2 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-2{width:100% !important;order : 0;}.fusion-builder-nested-column-2 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-3 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-14\" style=\"transform:translate3d(0,0,0);\"><p><strong>Haloperidol para el tratamiento de la atrofia muscular espinal<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-15\" style=\"transform:translate3d(0,0,0);\"><p><strong>Group:<\/strong> Gen\u00f3mica Traslacional Humana<\/p>\n<\/div><div class=\"fusion-text fusion-text-16\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patente<\/p>\n<\/div><div class=\"fusion-text fusion-text-17\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2024\/08\/Oferta-tecnologica_es_2024-1.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-3{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-3 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-3{width:50% !important;order : 0;}.fusion-builder-nested-column-3 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-3{width:100% !important;order : 0;}.fusion-builder-nested-column-3 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-4 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-18\" style=\"transform:translate3d(0,0,0);\"><p><strong>AMMON-OHE: A Machine Learning Model to Predict Occurrence of Overt Hepatic Encephalopathy in Patients with Cirrhosis <\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-19\" style=\"transform:translate3d(0,0,0);\"><p><strong>Group:<\/strong> Research Group on Neurological Impairment<\/p>\n<\/div><div class=\"fusion-text fusion-text-20\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-21\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/04\/i2023_05_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-4{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-4 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-4{width:50% !important;order : 0;}.fusion-builder-nested-column-4 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-4{width:100% !important;order : 0;}.fusion-builder-nested-column-4 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-5 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-22\" style=\"transform:translate3d(0,0,0);\"><p><strong>Device for blood cannulation for haemodialysis<\/strong><\/p>\n<div class=\"fusion-text fusion-text-22\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-24\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-25\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/04\/Tecnological-offer_i2024-35_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-5{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-5 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-5{width:50% !important;order : 0;}.fusion-builder-nested-column-5 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-5{width:100% !important;order : 0;}.fusion-builder-nested-column-5 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-6 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-26\" style=\"transform:translate3d(0,0,0);\"><p><strong>SepAsT: Software for early sepsis diagnosis of sepsis and patients clinical clourse and septic shock<\/strong><\/p>\n<div class=\"fusion-text fusion-text-26\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Research Group on Epigenomics and Translational Epigenetics<\/p>\n<\/div><div class=\"fusion-text fusion-text-28\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-29\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/04\/Oferta-tecnologica__i2024_33_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-6{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-6 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-6{width:50% !important;order : 0;}.fusion-builder-nested-column-6 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-6{width:100% !important;order : 0;}.fusion-builder-nested-column-6 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-7 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-30\" style=\"transform:translate3d(0,0,0);\"><p><strong>Musashi 2 (MSI2) como diana terap\u00e9utica para el tratamiento de la distrofia miot\u00f3nica tipo 1 y 2<\/strong><\/p>\n<div class=\"fusion-text fusion-text-30\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Research Group on Human Translational Genomics<\/p>\n<\/div><div class=\"fusion-text fusion-text-32\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-33\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/03\/i2019_16_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-7{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-7 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-7{width:50% !important;order : 0;}.fusion-builder-nested-column-7 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-7{width:100% !important;order : 0;}.fusion-builder-nested-column-7 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-8 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-34\" style=\"transform:translate3d(0,0,0);\"><p><strong>Method for minimal residual disease detection in cancer patients<\/strong><\/p>\n<div class=\"fusion-text fusion-text-34\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> : Research Group of Innovative Diagnostic and Therapeutical Developments in Solid Tumors<\/p>\n<\/div><div class=\"fusion-text fusion-text-36\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-37\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/05\/i2025_01_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Descripci\u00f3n<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-8{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-8 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-8{width:50% !important;order : 0;}.fusion-builder-nested-column-8 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-8{width:100% !important;order : 0;}.fusion-builder-nested-column-8 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-9 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-38\" style=\"transform:translate3d(0,0,0);\"><p><strong>Nanoparticles-based therapy for ischemic cardiopathies<\/strong><\/p>\n<div class=\"fusion-text fusion-text-38\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Grupo de Investigaci\u00f3n Traslacional en Cardiopat\u00eda Isqu\u00e9mica<\/p>\n<\/div><div class=\"fusion-text fusion-text-40\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type:<\/strong> Patent<\/p>\n<\/div><div class=\"fusion-text fusion-text-41\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/09\/Technology-offer_i2024_36_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-9{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-9 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-9{width:50% !important;order : 0;}.fusion-builder-nested-column-9 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-9{width:100% !important;order : 0;}.fusion-builder-nested-column-9 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-10 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-42\" style=\"transform:translate3d(0,0,0);\"><p><strong>Microbiological Information Bulletin(BIMIC)<\/strong><\/p>\n<div class=\"fusion-text fusion-text-42\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Grupo de Investigaci\u00f3n en Microbiolog\u00eda Molecular y Patog\u00e9nesis Microbiana<\/p>\n<\/div><div class=\"fusion-text fusion-text-44\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-45\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/10\/i2024_31_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-10{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-10 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-10{width:50% !important;order : 0;}.fusion-builder-nested-column-10 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-10{width:100% !important;order : 0;}.fusion-builder-nested-column-10 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-11 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-46\" style=\"transform:translate3d(0,0,0);\"><p><strong>EndosCitas y EndosNet<\/strong><\/p>\n<div class=\"fusion-text fusion-text-46\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Servicio de Medicina Digestiva \/ Unidad de endoscopias<\/p>\n<\/div><div class=\"fusion-text fusion-text-48\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-49\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/11\/Oferta-Tecnologica_i2024_30.pdf\" target=\"_blank\" rel=\"noopener\">Descripci\u00f3n<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-11{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-11 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-11{width:50% !important;order : 0;}.fusion-builder-nested-column-11 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-11{width:100% !important;order : 0;}.fusion-builder-nested-column-11 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-12 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-50\" style=\"transform:translate3d(0,0,0);\"><p><strong>Angiopath<\/strong><\/p>\n<div class=\"fusion-text fusion-text-50\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Grupo de Investigaci\u00f3n Translacional de Tumores S\u00f3lidos Pedi\u00e1tricos<\/p>\n<\/div><div class=\"fusion-text fusion-text-52\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-53\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2025\/11\/F-UAI-Tran-1_Angiopath_ES.pdf\" target=\"_blank\" rel=\"noopener\">Descripci\u00f3n<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-12{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-12 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-12{width:50% !important;order : 0;}.fusion-builder-nested-column-12 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-12{width:100% !important;order : 0;}.fusion-builder-nested-column-12 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-13 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-54\" style=\"transform:translate3d(0,0,0);\"><p><strong>HISTSHOCK IVD: A diagnostic and Decision-Support Software for Sepsis and Septic Shock Management<\/strong><\/p>\n<div class=\"fusion-text fusion-text-54\" style=\"transform:translate3d(0,0,0);\"><\/div>\n<p><strong>Group:<\/strong> Epigen\u00f3mica y Epigen\u00e9tica traslacional<\/p>\n<\/div><div class=\"fusion-text fusion-text-56\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-57\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/01\/251110_Oferta-tecnologica__i2025_19_Histshock_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-13{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-13 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-13{width:50% !important;order : 0;}.fusion-builder-nested-column-13 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-13{width:100% !important;order : 0;}.fusion-builder-nested-column-13 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-14 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-58\" style=\"transform:translate3d(0,0,0);\"><p><strong>Algorithmic methodology for opportunistic detection and monitoring of chronic kidney disease<\/strong><\/p>\n<p><div class=\"fusion-text fusion-text-58\" style=\"transform:translate3d(0,0,0);\"><\/div><strong>Group:<\/strong> Renal Disease Group<\/p>\n<\/div><div class=\"fusion-text fusion-text-60\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Know-how<\/p>\n<\/div><div class=\"fusion-text fusion-text-61\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/02\/i2024_17_Technological-offer_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-14{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-14 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-14{width:50% !important;order : 0;}.fusion-builder-nested-column-14 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-14{width:100% !important;order : 0;}.fusion-builder-nested-column-14 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-15 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-62\" style=\"transform:translate3d(0,0,0);\"><p><strong>LIPACS-PAT: Prescription support tool for lipid-lowering therapy after acute coronary syndrome<\/strong><\/p>\n<p><div class=\"fusion-text fusion-text-62\" style=\"transform:translate3d(0,0,0);\"><\/div><strong>Group:<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-64\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-65\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/09\/Oferta-tecnologica_i2024_06_LIPACS-PAT_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-15{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-15 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-15{width:50% !important;order : 0;}.fusion-builder-nested-column-15 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-15{width:100% !important;order : 0;}.fusion-builder-nested-column-15 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-16 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-66\" style=\"transform:translate3d(0,0,0);\"><p><strong>Left ventricular thrombus risk calculation tool after myocardial infarction<\/strong><\/p>\n<p><div class=\"fusion-text fusion-text-66\" style=\"transform:translate3d(0,0,0);\"><\/div><strong>Group:<\/strong><\/p>\n<\/div><div class=\"fusion-text fusion-text-68\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Software<\/p>\n<\/div><div class=\"fusion-text fusion-text-69\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/09\/Oferta-tecnologica_i2026_24_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-16{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-16 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-16{width:50% !important;order : 0;}.fusion-builder-nested-column-16 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-16{width:100% !important;order : 0;}.fusion-builder-nested-column-16 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style>\n<div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-17 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 30px 0px;\"><div class=\"fusion-text fusion-text-70\" style=\"transform:translate3d(0,0,0);\"><p><strong>Subcutaneous port for administration of heparins<\/strong><\/p>\n<p><div class=\"fusion-text fusion-text-70\" style=\"transform:translate3d(0,0,0);\"><\/div><strong>Group:<\/strong> Grupo Cl\u00ednico Asociado de Investigaci\u00f3n en Cuidados de la Salud. INVESTENF-INCLIVA<\/p>\n<\/div><div class=\"fusion-text fusion-text-72\" style=\"transform:translate3d(0,0,0);\"><p><strong>Type: <\/strong>Device<\/p>\n<\/div><div class=\"fusion-text fusion-text-73\" style=\"transform:translate3d(0,0,0);\"><p><a href=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2026\/09\/Oferta-tecnologica-i2025_03_ENG.pdf\" target=\"_blank\" rel=\"noopener\">Description<\/a><\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-nested-column-17{width:50% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-nested-column-17 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 3.84%;padding-bottom : 30px !important;padding-left : 0px !important;margin-left : 3.84%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-nested-column-17{width:50% !important;order : 0;}.fusion-builder-nested-column-17 > .fusion-column-wrapper {margin-right : 3.84%;margin-left : 3.84%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-nested-column-17{width:100% !important;order : 0;}.fusion-builder-nested-column-17 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div>\n<h2>\u00a0<\/h2>\n<h2>Technology-based Spin-Off companies:<\/h2>\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\" style=\"width:100%;max-width:250px;margin-top:20px;margin-bottom:20px;\"><a class=\"fusion-no-lightbox\" href=\"https:\/\/www.seqplexing.com\/\" target=\"_blank\" aria-label=\"Seqplexing\" rel=\"noopener noreferrer\"><img width=\"200\" height=\"66\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing-200x66.jpg\" class=\"img-responsive wp-image-8218\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing-200x66.jpg 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing-400x132.jpg 400w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing-600x198.jpg 600w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Seqplexing.jpg 744w\" sizes=\"(max-width: 640px) 100vw, 200px\" \/><\/a><\/span><\/div>\n<p><strong>Seqplexing<\/strong> was founded in 2013 with the aim of developing solutions for research and clinical applications based on advanced genetic techniques and platforms, particularly next-generation sequencing (NGS). The company addresses the need for reliable protocols for amplicon and gene sequencing by developing ready-to-use solutions that can be easily implemented in laboratories.<\/p>\n<p>Seqplexing\u2019s mission is to support laboratories that, due to the demands of their day-to-day activities, lack the time or resources to develop optimised protocols for sequencing genes or regions of interest. The company transforms the components required for these techniques into commercial kits, providing a comprehensive service covering the entire workflow, from sample preparation to the final analysis of results.<\/p>\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-2 hover-type-none\" style=\"width:100%;max-width:250px;margin-top:20px;margin-bottom:20px;\"><a class=\"fusion-no-lightbox\" href=\"http:\/\/www.epidisease.com\/\" target=\"_blank\" aria-label=\"Epidisease Logo Carnet\" rel=\"noopener noreferrer\"><img width=\"437\" height=\"142\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Epidisease-Logo-Carnet.jpg\" class=\"img-responsive wp-image-8216\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Epidisease-Logo-Carnet-200x65.jpg 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Epidisease-Logo-Carnet-400x130.jpg 400w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/Epidisease-Logo-Carnet.jpg 437w\" sizes=\"(max-width: 640px) 100vw, 437px\" \/><\/a><\/span><\/div>\n<p><strong>Epidisease <\/strong>was founded in 2014 as a result of a project led by researchers from INCLIVA and the Biomedical Research Networking Centre (CIBER) in the field of Rare Diseases, with the aim of translating expertise in epigenetics and biomedical sciences into solutions that benefit society.<\/p>\n<p>Epigenetics studies the factors and mechanisms involved in regulating gene expression. The importance of this field continues to grow, as findings arising from initiatives such as the Human Genome Project have shown that the molecular basis of cellular function, development, ageing and many diseases extends far beyond the DNA sequence itself. More recent findings from the Roadmap Epigenomics Project have further advanced our understanding of these mechanisms.<\/p>\n<p>Epidisease\u2019s mission is to leverage its extensive expertise in epigenetics to provide its clients with biomedical solutions, diagnostic tools and new therapies, while promoting translational research aimed at improving human health and well-being.<\/p>\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-3 hover-type-none\" style=\"width:100%;max-width:250px;margin-top:20px;margin-bottom:20px;\"><a class=\"fusion-no-lightbox\" href=\"http:\/\/www.nelabiodynamics.com\/\" target=\"_blank\" aria-label=\"LOGO_nela\" rel=\"noopener noreferrer\"><img width=\"500\" height=\"121\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/LOGO_nela.png\" class=\"img-responsive wp-image-8217\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/LOGO_nela-200x48.png 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/LOGO_nela-400x97.png 400w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/LOGO_nela.png 500w\" sizes=\"(max-width: 640px) 100vw, 500px\" \/><\/a><\/span><\/div>\n<p><strong>Nela BioDynamics <\/strong>is a biomedical technology development company that emerged from collaboration within the Valencian university ecosystem. Its multidisciplinary team brings together researchers with expertise in biomedicine and engineering.<\/p>\n<p>The company originated from the results of a Master\u2019s Thesis in Biomedical Engineering, which led to two patents covering a novel intramedullary fixation system for joint endoprostheses, fracture nails and exoprostheses, as well as a percutaneous collar for ostomies.<\/p>\n<p>NELA\u2019s intramedullary implant technology enables a personalised fit for each patient and avoids conventional fixation techniques based on impact press-fitting or the use of bone cement. This can result in shorter surgical procedures, reduced pain, improved success rates and a better quality of life for patients.<\/p>\n<p>NELA\u2019s mission is to address unmet medical needs while generating a positive socioeconomic impact.<\/p>\n<div ><span class=\" fusion-imageframe imageframe-none imageframe-4 hover-type-none\" style=\"width:100%;max-width:250px;margin-top:20px;margin-bottom:20px;\"><a class=\"fusion-no-lightbox\" href=\"https:\/\/arthexbiotech.com\/\" target=\"_blank\" aria-label=\"1605864958807\" rel=\"noopener noreferrer\"><img width=\"750\" height=\"249\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807.jpg\" class=\"img-responsive wp-image-8215\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807-200x66.jpg 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807-400x133.jpg 400w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807-600x199.jpg 600w, https:\/\/www.incliva.es\/wp-content\/uploads\/2021\/05\/1605864958807.jpg 750w\" sizes=\"(max-width: 640px) 100vw, 750px\" \/><\/a><\/span><\/div>\n<p><strong>ARTHEx BIOTECH <\/strong>is a spin-off company from the Universitat de Val\u00e8ncia developing advanced RNA-based therapies for genetic diseases. Its team has extensive expertise in drug discovery and in the role of microRNAs in neuromuscular diseases. The company is also supported by internationally renowned scientific and clinical advisors who contribute their expertise to the successful development of its therapeutic programmes.<\/p>\n<p>ARTHEx Biotech\u2019s mission is to develop effective treatments for unmet medical needs. Its initial focus is on investigating anti-microRNA therapies for the treatment of myotonic dystrophy type 1 (DM1), a rare disease affecting more than 900,000 people worldwide, with an estimated prevalence of 1 in 8,000.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-1{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-1 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-1{width:100% !important;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-1{width:100% !important;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-2{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":13,"featured_media":0,"parent":10472,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/46275"}],"collection":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/comments?post=46275"}],"version-history":[{"count":10,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/46275\/revisions"}],"predecessor-version":[{"id":53340,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/46275\/revisions\/53340"}],"up":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/10472"}],"wp:attachment":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/media?parent=46275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}